Supplier: Abcam

Rabbit polyclonal to Connexin 43 / GJA1 - Intercellular Junction Marker.

Supplier: Abcam

Rabbit monoclonal [EPR21153] to Connexin 43 / GJA1.

Supplier: Abcam

Anti-CRP-1 Rabbit Monoclonal Antibody [clone: EPR14345-43]

Supplier: Abcam

Rabbit monoclonal [EPR13753-43] to BRAT1 - C-terminal.

Supplier: ANTIBODIES.COM

Rabbit polyclonal antibody to Connexin 43 for WB and ELISA with samples derived from Human, Mouse and Rat.

Supplier: Abcam

FITC Mouse monoclonal [C-43] to Cytokeratin 8.

Supplier: ANTIBODIES.COM

Rabbit polyclonal antibody to Connexin 43 (phospho Ser261) for IHC and ELISA with samples derived from Human.

Supplier: ANTIBODIES.COM

Rabbit polyclonal antibody to Connexin 43 for WB, IHC, IF and ELISA with samples derived from Human, Mouse and Rat.

Supplier: ANTIBODIES.COM

Mouse monoclonal [C-43] antibody to Cytokeratin 8 for IF, WB and IHC-P with samples derived from human, sheep, rabbit, bovine and porcine.

Supplier: OriGene

Anti-DLG4 Mouse Monoclonal Antibody [clone: S28-43]

Supplier: Boster Bio

Anti-NCAM Mouse Monoclonal Antibody [clone: IML-43]

Supplier: Biosensis

TAR DNA-binding protein 43 (TDP43) is a DNA and RNA-binding protein which regulates transcription and splicing (ref: SWISSPROT).

Supplier: Abcam

Rabbit monoclonal [EPR27325-43] to G3BP2 (isoform a).

Supplier: OriGene

Anti-IRF4 Rabbit Monoclonal Antibody [clone: MRQ-43]

Supplier: Abcam

Rabbit monoclonal [EPR28387-43] to Elf4/MEF.

Supplier: Abcam

Rabbit monoclonal [EPR24218-43] to KMT1E / SETDB1.

Supplier: ANTIBODIES.COM

Rabbit polyclonal antibody to Connexin 43 (phospho Ser367) for WB, IHC and ELISA with samples derived from Human, Mouse and Rat.

Supplier: Abcam

Rabbit monoclonal [EPR24167-43] to CDKN2A/p16INK4a.

Supplier: Abcam

Biotin Rabbit monoclonal [EPR11410-43] to Bcl6.

Supplier: Abcam

Rabbit polyclonal to Connexin 43 / GJA1 (phospho S368).

Supplier: ANTIBODIES.COM

Mouse monoclonal [MEM-43] antibody to CD59 for flow cytometry, IP and IHC-P with samples derived from human.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast.

Supplier: Abcam

Rabbit monoclonal [EPR28433-43] to CPLX3 - BSA and Azide free.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast.

Supplier: Biotium

Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (ring-like, perinuclear) from ductal (peripheral-predominant) carcinoma of the breast.

Supplier: Abcam

Rabbit monoclonal [EPR23288-43] to VIP - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR24658-43] to NFAT1 - BSA and Azide free.

Supplier: Abcam

Rabbit monoclonal [EPR27844-43] to HCN3 - BSA and Azide free.